A Monopoli Selected Research

A Monopoli Research Topics

2	Infarction (Infarctions) 08/2001 - 07/2000
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2011
1	Type 2 Diabetes Mellitus (MODY) 09/2011
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 04/2007
1	Atherosclerosis 01/2007
1	Pulmonary Embolism 11/2005
1	Brain Infarction 08/2001
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2001
1	Parkinson Disease (Parkinson's Disease) 01/2001
1	Brain Ischemia (Cerebral Ischemia) 07/2000
1	Lymphoma (Lymphomas) 01/2000
1	Panniculitis 01/2000

3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2011 - 01/2007
1	6-(nitrooxy)hexyl 7- (2- (4- fluorophenyl)- 5- isopropyl- 3- phenyl- 4- (phenylcarbamoyl)- 1H- pyrrol- 1- yl)- 3,5- dihydroxyheptanoateIBA 09/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2007
1	1,2,6,7,8,8a- hexahydro- beta,delta,6- trihydroxy- 2- methyl- 8- (2- methyl- 1- oxobutoxy)- 1- naphthaleneheptanoic acid 4-(nitrooxy)butyl esterIBA 11/2005
1	CollagenIBA 11/2005
1	Epinephrine (Adrenaline)FDA LinkGeneric 11/2005
1	MK-886IBA 08/2001
1	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 08/2001
1	cysteinyl-leukotrieneIBA 08/2001
1	LeukotrienesIBA 08/2001
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2001
1	Dizocilpine Maleate (Dizocilpine)IBA 08/2001
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 08/2001
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2001
1	istradefyllineIBA 01/2001
1	Neuroprotective AgentsIBA 07/2000
1	Sirolimus (Rapamycin)FDA Link 07/2000
1	GPI 1046IBA 07/2000
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2000

1	Drug Therapy (Chemotherapy) 01/2000